Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.36%42.08B | -19.43%41.1B | -22.85%9.96B | -28.18%10.89B | 20.28%12.72B | -39.06%7.54B | 55.28%51.02B | 42.97%12.91B | 48.09%15.16B | 35.83%10.57B |
| Cost of revenue | 3.82%37.71B | -21.32%36.32B | -26.94%8.75B | -29.10%9.73B | 20.98%11.31B | -41.25%6.53B | 59.78%46.16B | 49.04%11.98B | 51.05%13.72B | 37.85%9.35B |
| Gross profit | -8.71%4.37B | -1.42%4.79B | 29.86%1.21B | -19.50%1.16B | 15.00%1.41B | -19.89%1.01B | 22.47%4.86B | -6.34%931M | 24.76%1.44B | 22.33%1.23B |
| Operating expense | -1.57%3.51B | 3.45%3.57B | -7.39%890M | 11.84%850M | 13.34%1.01B | -2.27%818M | 3.54%3.45B | 13.19%961M | -20.34%760M | 15.25%892M |
| Selling and administrative expenses | -1.57%3.51B | 3.45%3.57B | ---- | ---- | ---- | ---- | 3.54%3.45B | ---- | ---- | ---- |
| -Selling and marketing expense | -10.18%1.07B | 11.23%1.19B | ---- | ---- | ---- | ---- | 2.00%1.07B | ---- | ---- | ---- |
| -General and administrative expense | 2.73%2.45B | -0.04%2.38B | ---- | ---- | ---- | ---- | 4.25%2.38B | ---- | ---- | ---- |
| Operating profit | -29.64%857M | -13.37%1.22B | 1,163.33%319M | -54.73%306M | 19.40%400M | -54.59%193M | 122.12%1.41B | -120.69%-30M | 243.15%676M | 46.29%335M |
| Net non-operating interest income (expenses) | -13.02%-356M | -1.94%-315M | -4.26%-98M | -8.45%-77M | 3.90%-74M | 1.49%-66M | 0.00%-309M | 2.08%-94M | 1.39%-71M | -2.67%-77M |
| Non-operating interest income | --0 | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non-operating interest expense | 14.04%333M | 2.46%292M | 7.14%75M | 8.45%77M | -3.90%74M | -1.49%66M | -0.35%285M | -4.11%70M | -1.39%71M | 2.67%77M |
| Total other finance cost | 0.00%23M | -4.17%23M | ---- | ---- | ---- | ---- | 4.35%24M | ---- | ---- | ---- |
| Net investment income | -31.82%75M | -16.67%110M | 100.00%2M | -41.98%47M | -25.00%3M | 26.09%58M | 312.50%132M | 0.00%1M | 406.25%81M | 0.00%4M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 411.11%28M | -9M | 0 | -9M | 0 | 0 | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 51.72%-14M | 82.10%-29M | 82.10%-29M | 200.00%1M | 0 | -1M | -248.62%-162M | -242.11%-162M | 80.00%-1M | 200.00%1M |
| Less:Other special charges | 125.00%9M | 108.89%4M | ---- | ---- | --0 | --1M | 58.72%-45M | ---- | ---- | ---- |
| Less:Write off | -80.00%5M | -87.92%25M | ---- | ---- | ---- | ---- | --207M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -1,400.00%-13M | -96.00%1M | 120.00%10M | 4.17%25M | -507.69%-53M | -50.00%19M | 4.17%25M | -394.12%-50M | 300.00%24M | 161.90%13M |
| Income before tax | -40.72%578M | -10.63%975M | 160.71%204M | -58.82%292M | -1.08%275M | -53.64%204M | 92.42%1.09B | -286.67%-336M | 219.37%709M | 104.41%278M |
| Income tax | -44.41%189M | -9.33%340M | 51.92%79M | -24.63%101M | 14.86%85M | -34.78%75M | 108.33%375M | -22.39%52M | 116.13%134M | 85.00%74M |
| Net income | -38.90%388M | -11.19%635M | 132.47%126M | -66.96%190M | -5.91%191M | -60.62%128M | 84.75%715M | -440.35%-388M | 261.64%575M | 109.28%203M |
| Net income continuous operations | -38.74%389M | -11.31%635M | 132.22%125M | -66.78%191M | -6.86%190M | -60.31%129M | 85.01%716M | -443.36%-388M | 259.38%575M | 112.50%204M |
| Noncontrolling interests | -25.00%6M | -61.90%8M | -200.00%-5M | -28.57%5M | 0.00%6M | -33.33%2M | 5.00%21M | 0.00%5M | 40.00%7M | 20.00%6M |
| Net income attributable to the company | -38.98%382M | -9.80%626M | 133.08%130M | -67.43%185M | -6.09%185M | -60.87%126M | 89.10%694M | -460.55%-393M | 266.45%568M | 116.48%197M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -38.98%382M | -9.80%626M | 133.08%130M | -67.43%185M | -6.09%185M | -60.87%126M | 89.10%694M | -460.55%-393M | 266.45%568M | 116.48%197M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -38.98%49.16 | -9.72%80.57 | 133.19%16.76 | -67.39%23.8 | -6.16%23.78 | -60.81%16.23 | 89.15%89.24 | -462.53%-50.5 | 265.32%72.99 | 117.14%25.34 |
| Diluted earnings per share | -38.98%49.16 | -9.72%80.57 | 133.08%16.7111 | -67.42%23.7811 | -6.09%23.78 | -60.81%16.23 | 89.15%89.24 | -462.65%-50.5177 | 266.34%72.99 | 116.99%25.3231 |
| Dividend per share | 0.00%39 | -9.30%39 | -9.30%39 | 0 | 0 | 0 | 30.30%43 | 30.30%43 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |